| Code | 2513D | ||||||||||
| MA number | 31/0294/19-S | ||||||||||
| Product Form: | tbl 90x10 mg/40 mg (blis.OPA/Al/PVC) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Zentiva, k.s., Czechia | ||||||||||
| Therapeutic Class: | 31 - HYPOLIPIDAEMICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister OPA/Al/PVC | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10b fixed combination application |
| MA issued: | 26.09.2019 |
| PIL: |
PIL_Zetovar tablety_06.2025.pdf
|
| SPC: |
SPC_Zetovar tablety_06.2025.pdf
|
| Safety feature | Yes |
| Data update: | 15.04.2024 |
